Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
BackgroundBecause the κ-opioid receptor (OR) agonist U50488H stimulates opioidergic regulation and inhibits L-type Ca2+ channels, this study was aimed at assessing the roles of OR and L-type Ca2+ channels on U50488H-induced cardioprotection.MethodsLangendorff-perfused rat hearts were subjected to 30...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Anesthesiologists
2010-02-01
|
Series: | Korean Journal of Anesthesiology |
Subjects: | |
Online Access: | http://ekja.org/upload/pdf/kjae-58-162.pdf |
id |
doaj-4614effb928f490a8b21fc0992973805 |
---|---|
record_format |
Article |
spelling |
doaj-4614effb928f490a8b21fc09929738052020-11-25T03:43:53ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632010-02-0158216216810.4097/kjae.2010.58.2.1626843Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulationKook Jin Chun0Young Ho Jang1June Hong Kim2Jun Kim3Yong Hyun Park4Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.BackgroundBecause the κ-opioid receptor (OR) agonist U50488H stimulates opioidergic regulation and inhibits L-type Ca2+ channels, this study was aimed at assessing the roles of OR and L-type Ca2+ channels on U50488H-induced cardioprotection.MethodsLangendorff-perfused rat hearts were subjected to 30 min of regional ischemia and 2 h of reperfusion. Isolated hearts were treated with U50488H with or without the κ-OR antagonist nor-binaltorphimine (nor-BNI) or the Ca2+ channels activator BAY K 8644. Infarct size was measured with 2,3,5-triphenyltetrazolium chloride staining.ResultsU50488H treatment at reperfusion: (1) significantly reduced infarct size (11.3 ± 1.3%) compared to control hearts (27.7 ± 1.1%, P < 0.001), an effect that was completely blocked by nor-BNI (24.0 ± 0.9%, P < 0.001 vs. U50488H) but not by BAY K 8644 (7.1 ± 1.7%, P > 0.05 vs. U50488H); (2) significantly increased left ventricular developed pressure (65.3 ± 4.8%) after 2 h of reperfusion compared to control hearts (44.8 ± 3.6%, P < 0.05), an effect that was abrogated by nor-BNI (40.5 ± 4.5%, P > 0.05 vs. control) but not by BAY K 8644 (64.3 ± 5.6%, P < 0.01 vs. control); and (3) significantly decreased heart rate (P < 0.01 vs. control), an effect that was completely abrogated by both nor-BNI and BAY K 8644.ConclusionsU50488H significantly limits myocardial infarction and stunning in isolated rat hearts after ischemia-reperfusion induction. The infarct size limitation and contractility improvement observed with U50488H treatment during reperfusion are entirely mediated by OR stimulation and not by Ca2+ channel modulation.http://ekja.org/upload/pdf/kjae-58-162.pdfcoronary occlusionmyocardial infarctionopioid receptorsreperfusion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kook Jin Chun Young Ho Jang June Hong Kim Jun Kim Yong Hyun Park |
spellingShingle |
Kook Jin Chun Young Ho Jang June Hong Kim Jun Kim Yong Hyun Park Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation Korean Journal of Anesthesiology coronary occlusion myocardial infarction opioid receptors reperfusion |
author_facet |
Kook Jin Chun Young Ho Jang June Hong Kim Jun Kim Yong Hyun Park |
author_sort |
Kook Jin Chun |
title |
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation |
title_short |
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation |
title_full |
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation |
title_fullStr |
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation |
title_full_unstemmed |
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation |
title_sort |
cardioprotection by kappa-opioid receptor agonist u50488h is mediated by opioidergic regulation but not by calcium current modulation |
publisher |
Korean Society of Anesthesiologists |
series |
Korean Journal of Anesthesiology |
issn |
2005-6419 2005-7563 |
publishDate |
2010-02-01 |
description |
BackgroundBecause the κ-opioid receptor (OR) agonist U50488H stimulates opioidergic regulation and inhibits L-type Ca2+ channels, this study was aimed at assessing the roles of OR and L-type Ca2+ channels on U50488H-induced cardioprotection.MethodsLangendorff-perfused rat hearts were subjected to 30 min of regional ischemia and 2 h of reperfusion. Isolated hearts were treated with U50488H with or without the κ-OR antagonist nor-binaltorphimine (nor-BNI) or the Ca2+ channels activator BAY K 8644. Infarct size was measured with 2,3,5-triphenyltetrazolium chloride staining.ResultsU50488H treatment at reperfusion: (1) significantly reduced infarct size (11.3 ± 1.3%) compared to control hearts (27.7 ± 1.1%, P < 0.001), an effect that was completely blocked by nor-BNI (24.0 ± 0.9%, P < 0.001 vs. U50488H) but not by BAY K 8644 (7.1 ± 1.7%, P > 0.05 vs. U50488H); (2) significantly increased left ventricular developed pressure (65.3 ± 4.8%) after 2 h of reperfusion compared to control hearts (44.8 ± 3.6%, P < 0.05), an effect that was abrogated by nor-BNI (40.5 ± 4.5%, P > 0.05 vs. control) but not by BAY K 8644 (64.3 ± 5.6%, P < 0.01 vs. control); and (3) significantly decreased heart rate (P < 0.01 vs. control), an effect that was completely abrogated by both nor-BNI and BAY K 8644.ConclusionsU50488H significantly limits myocardial infarction and stunning in isolated rat hearts after ischemia-reperfusion induction. The infarct size limitation and contractility improvement observed with U50488H treatment during reperfusion are entirely mediated by OR stimulation and not by Ca2+ channel modulation. |
topic |
coronary occlusion myocardial infarction opioid receptors reperfusion |
url |
http://ekja.org/upload/pdf/kjae-58-162.pdf |
work_keys_str_mv |
AT kookjinchun cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation AT younghojang cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation AT junehongkim cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation AT junkim cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation AT yonghyunpark cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation |
_version_ |
1724517805784563712 |